SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001341004-24-000056
Filing Date
2024-03-05
Accepted
2024-03-05 17:42:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D, AMENDMENT NO. 8 sc13da8.htm SC 13D/A 32140
  Complete submission text file 0001341004-24-000056.txt   33497
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Subject) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91017 | Film No.: 24722713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O APPLIED THERAPEUTICS, INC. 340 MADISON AVENUE, 19TH FLOOR NEW YORK NY 10173
Business Address
Shendelman Shoshana (Filed by) CIK: 0001775490 (see all company filings)

Type: SC 13D/A